6 results about "Scabiosa" patented technology

The invention belongs to the technical field of environmental sanitation and disinfection, and particularly relates to application of a smoke insecticide containing 5% cypermethrin in preparation of a medicine and a method for disinfecting a scabies environment. The smoke insecticide forms a smoke agent at high temperature, effectively diffuses in a closed space and kills sarcoptic mites, and has the advantages of high efficiency, low toxicity, simplicity and convenience in operation, low cost and the like. The method is especially suitable for crowded places, such as nursing homes and schools, can effectively prevent and control the outbreak and spread of scabies, and guarantees the public health safety.

A new cultivar of Scabiosa plant named ‘Lier 01’ that is characterized by its compact plant habit, its floriferous blooming habit, its dark blue flowers, and its moderate growth habit.

The invention relates to the technical field of biological medicine, in particular to a non-medicinal part and extract of Mongolian medicine scabiosa and application of the non-medicinal part and extract in the aspect of liver fibrosis resistance. The scabiosa has the effects of clearing heat, improving eyesight, clearing heat and coordinating the day. The Tibetan medicine uses papaveris meconopsis as the dry inflorescence of meconopsis longleaf, meconopsis valvata and meconopsis wuveitana, and the effects of the two are considered to be similar. The invention aims to provide a technical scheme of the non-medicinal part and the extract of scabiosa scabiosa in anti-hepatic fibrosis and research and development of corresponding medicines, and application of the non-medicinal part or the extract of the non-medicinal part in preparation of medicines for treating and relieving liver injury, hepatic fibrosis, liver cirrhosis and the like. Pharmacological studies on inflorescence, stem leaves, meconopsis wuveolens chemical components and in-blood component networks of scabiosa coreana show that the scabiosa coreana and meconopsis wuveolens have similar effects, have obvious effects of relieving carbon tetrachloride acute liver injury, resisting hepatic fibrosis and reducing AST and ALT, and belong to low-toxicity drugs.

The invention provides an external preparation for treating pruritic skin diseases and a preparation method thereof, and belongs to the technical field of pharmaceutical preparations. The traditional Chinese medicine composition is prepared from the following components: radix sophorae flavescentis, fructus xanthii, flos chrysanthemi indici, fructus cnidii, flos lonicerae, fructus kochiae, radix stemonae and cortex dictamni. The invention also provides a method for preparing an external preparation by using the traditional Chinese medicine composition, and the obtained external preparation is clear in clinical positioning, is suitable for external treatment of eczema, scabies, tinea of feet and hands, dermatitis, skin pruritus and other pruritus skin diseases, has better effects of relieving itching, resisting inflammation and improving skin lesion, and has a wide application prospect. Good clinical application prospects are realized in practical application.

A new cultivar of Scabiosa plant named ‘Lier 01’ that is characterized by its compact plant habit, its floriferous blooming habit, its dark blue flowers, and its moderate growth habit.

The invention relates to the technical field of biological medicine, in particular to a non-medicinal part and extract of Mongolian medicine scabiosa and application of the non-medicinal part and extract in the aspect of liver fibrosis resistance. The scabiosa has the effects of clearing heat, improving eyesight, clearing heat and coordinating the day. The Tibetan medicine uses papaveris meconopsis as the dry inflorescence of meconopsis longleaf, meconopsis valvata and meconopsis wuveitana, and the effects of the two are considered to be similar. The invention aims to provide a technical scheme of the non-medicinal part and the extract of scabiosa scabiosa in anti-hepatic fibrosis and research and development of corresponding medicines, and application of the non-medicinal part or the extract of the non-medicinal part in preparation of medicines for treating and relieving liver injury, hepatic fibrosis, liver cirrhosis and the like. Pharmacological studies on inflorescence, stem leaves, meconopsis wuveolens chemical components and in-blood component networks of scabiosa coreana show that the scabiosa coreana and meconopsis wuveolens have similar effects, have obvious effects of relieving carbon tetrachloride acute liver injury, resisting hepatic fibrosis and reducing AST and ALT, and belong to low-toxicity drugs.